Item 5.02         Departure of Directors or Certain Officers; Election of Directors;
                  Appointment of Certain Officers; Compensatory Arrangements of Certain
                  Officers.

On April 15, 2021, NeoGenomics, Inc. (the "Company") accepted notice from Robert J. Shovlin, its President, Clinical Services Division, of his intention to retire from that position effective June 4, 2021. Thereafter, Mr. Shovlin will serve as an advisor to the Company's Chief Executive Officer.

© Edgar Online, source Glimpses